S100B and breast carcinoma: Taken together, these molecular studies provided us with a model of S100β production in endocrine resistant breast cancer where endocrine treatment can induce rapid tyrosine kinase signaling to induce HOXC11/SRC-1 transcriptional activation of S100β.